Center-Authored Papers

Filters: Author is Carpenter, P A  [Clear All Filters]
Journal Article
Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Deeg HJ, Appelbaum FR, Anasetti C, Storb R et al..  2004.  Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.. Bone marrow transplantation. 33(8):805-14. Abstract
Sanders JE, Im HJ, Hoffmeister PA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Bryant EM, Appelbaum FR.  2005.  Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.. Blood. 105(9):3749-56. Abstract
Inamoto Y, Martin PJ, Paczesny S, Tabellini L, Momin AA, Mumaw CL, Flowers MED, Lee SJ, Carpenter PA, Storer BE et al..  2017.  Association of plasma CD163 concentration with de novo-onset chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Inamoto Y, Sun Y-C, Flowers MED, Carpenter PA, Martin PJ, Li P, Wang R, Chai X, Storer BE, Shen TT et al..  2015.  Bandage soft contact lenses for ocular graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(11):2002-7. Abstract
Newell LF, Flowers MED, Gooley TA, Milano F, Carpenter PA, Martin PJ, Delaney C.  2013.  Characteristics of chronic GVHD after cord blood transplantation.. Bone marrow transplantation. 48(10):1285-90. Abstract
Inamoto Y, Martin PJ, Chai X, Jagasia M, Palmer J, Pidala J, Cutler C, Pavletic SZ, Arora M, Jacobsohn D et al..  2012.  Clinical Benefit of Response in Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(10):1517-24. Abstract
Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem H-P, Petersdorf EW, Pereira S, Nash RA, Mielcarek M, Fero ML et al..  2011.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.. Blood. 117(11):3214-9. Abstract
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers MED, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT et al..  2011.  Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1):124-32. Abstract
Bubalo J, Carpenter PA, Majhail N, Perales M-A, Marks DI, Shaughnessy P, Pidala J, Leather HL, Wingard J, Savani BN.  2014.  Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Aki SZ, Inamoto Y, Carpenter PA, Storer BE, Sandmaier BM, Lee SJ, Martin PJ, Flowers MED.  2016.  Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity.. Bone marrow transplantation. 51(10):1350-1353. Abstract
Travi G, Pergam SA, Xie H, Carpenter PA, Kiem H-P, Corey L, Boeckh MJ.  2009.  The effect of imatinib on cytomegalovirus reactivation in hematopoietic cell transplantation.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 49(11):e120-3. Abstract
Mielcarek M, Furlong T, Storer BE, Green ML, McDonald GB, Carpenter PA, Flowers MED, Storb R, Boeckh MJ, Martin PJ.  2015.  Effectiveness and safety of lower-dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.. Haematologica. 100(6):842-8. Abstract
Martin PJ, Storer BE, Inamoto Y, Flowers MED, Carpenter PA, Pidala J, Palmer J, Arora M, Jagasia M, Arai S et al..  2017.  An endpoint associated with clinical benefit after initial treatment for chronic graft-versus-host disease.. Blood. Abstract
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem H-P, Fero ML, Warren EH, Lee SJ, Appelbaum FR et al..  2009.  Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.. Blood. 114(3):702-8. Abstract
Inamoto Y, Flowers MED, Sandmaier BM, Aki SZ, Carpenter PA, Lee SJ, Storer BE, Martin PJ.  2014.  Failure-free survival after initial systemic treatment of chronic graft-versus host disease.. Blood. 124(8):1363-71. Abstract
Inamoto Y, Storer BE, Lee SJ, Carpenter PA, Sandmaier BM, Flowers MED, Martin PJ.  2013.  Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.. Blood. 121(12):2340-6. Abstract
Martin PJ, Rizzo DJ, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR et al..  2012.  First and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Lee SJ, Seaborn T, Mao FJ, Massey SC, Luu NQ, Schubert MA, Chien JW, Carpenter PA, Moravec C, Martin PJ et al..  2009.  Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(4):416-20. Abstract
Cutler C, Kesselheim A, Gabardi S, Andersson BS, Carpenter PA, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H et al..  2011.  Generic immunosuppressants in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):285-90.
Inamoto Y, Martin PJ, Flowers MED, Lee SJ, Carpenter PA, Warren EH, Geraghty DE, Lee N, Boeckh MJ, Storer BE et al..  2016.  Genetic risk factors for sclerotic graft-versus-host disease.. Blood. 128(11):1516-1524. Abstract
Majhail NS, Flowers MED, Ness KK, Jagasia M, Carpenter PA, Arora M, Arai S, Johnston L, Martin PJ, Baker KS et al..  2009.  High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 43(1):49-54. Abstract
Carpenter PA.  2011.  How I conduct a comprehensive chronic graft-versus-host disease assessment.. Blood. 118(10):2679-87. Abstract
Carpenter PA, Englund JA.  2016.  How I vaccinate blood and marrow transplant recipients.. Blood. Abstract
El-Jawahri A, Pidala J, Inamoto Y, Chai X, Khera N, Wood WA, Cutler C, Arora M, Carpenter PA, Palmer J et al..  2014.  Impact of Age on Quality of Life, Functional Status and Survival in Patients with Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract